Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the experiments reported here, we investigated chlorpromazine (CPZ)-induced (CPZ)-induced enhancement of the cat cerebellar potentials evoked by peripheral nerve stimulation, with regard to the subtypes of adrenoceptor in the nucleus reticularis lateralis (
LRN
). Electrical stimulus of the locus coeruleus (LC) at high frequencies enhanced cerebellar potentials evoked by peripheral nerve stimulation. Although similar stimulus increased them after pretreatment with an alpha 2-antagonist, yohimbine, these enhancements were not recognized by pretreatment with an alpha 1-antagonist, prazosin. Microinjection of norepinephrine (NE: 10 micrograms) into
LRN
decreased cerebellar potentials, and conversely, 30 micrograms of NE significantly increased them. Although microinjection of an alpha 2-adrenoceptor agonist, clonidine, into the
LRN
depressed cerebellar potentials, clonidine-induced decrease was obviously antagonized by pretreatment with CPZ. Furthermore, an alpha 1-adrenoceptor agonist, phenylephrine, into the
LRN
increased cerebellar potentials. Pretreatment with CPZ hardly changed phenylephrine-induced enhancement. We though that CPZ blocked alpha 2-autoreceptors in adrenergic terminals from the LC rather than alpha 1-adrenoceptors within the
LRN
. As a result, NE released from the LC terminals may act on alpha 1-adrenoceptors in the
LRN
and may attenuate activities of the
LRN
. Therefore, it was clear that previous CPZ-induced enhancement may be due to
depression
of the descending inhibitory adrenergic system via CPZ-induced blockade of alpha 2-autoreceptors.
...
PMID:Effects of chlorpromazine in the nucleus reticularis lateralis on the cat cerebellar potentials. 255 41
1) In the experiments reported here, we investigated effects of CPZ on the amplitude of cerebellar potentials using decerebrated or spinal cat; furthermore, we also examined the effects of microinjecting CPZ, DA or NE into the precerebellar nuclei on the amplitude of the cerebellar potentials. 2) Purkinje cell spontaneous discharge was either hardly changed or was depressed by CPZ. 3) CPZ did not change the potentials evoked by peripheral stimulation on the dorsal surface of the spinal cord. 4) CPZ depressed significantly the cerebellar potentials evoked by stimulation of the nucleus reticularis lateralis (
LRN
) or nucleus olivaris inferior (ION) in intact, decerebrated and spinal cats. 5) The cerebellar potentials evoked by the peripheral nerve stimulation were increased by microinjection of CPZ into the bilateral
LRN
but not into the bilateral ION. Microinjection of NE or CPZ into the contralateral
LRN
hardly influenced the cerebellar evoked potentials. 6) Although electrical stimulation at high frequencies of the ipsilateral
LRN
depressed significantly the cerebellar evoked potentials; similar stimulation after i.v. pretreatment of CPZ failed to affect them. Microinjection of CPZ into the ipsilateral
LRN
enhanced the cerebellar evoked potentials, and microinjection of NE or DA depressed them significantly. Furthermore, after pretreatment with CPZ, microinjection of DA failed to depress the potentials. 7) We suggest that intravenous CPZ-induced enhancement of the cerebellar potentials may be due to
depression
of the descending inhibitory mechanism, resulting from CPZ-induced blockage of the catecholamine receptors of the ipsilateral
LRN
and of the spinal level.
...
PMID:Studies of chlorpromazine-induced enhancement of the potentials evoked by peripheral stimulation of the cat cerebellum. 365 85